Search Results 2771-2780 of 13403 for monoclonal antibody

  1. Hematology - Clinical trials

    ... antibodies and the factors that may determine disease progression and treatment response. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy.

  2. Minnesota - Mayo Clinic News Network

    ROCHESTER, Minn. — Mayo Clinic Platform today announced that its Accelerate program for healthcare technology companies is now available through a multiyear ...

  3. Multiple myeloma - Doctors and departments - Mayo Clinic

    Bispecific antibody therapy · Bone marrow transplant · Cancer treatment · CAR-T cell therapy · Chemotherapy · Complete blood count (CBC) · Creatinine test · CT ...

  4. Multiple myeloma - Doctors and departments - Mayo Clinic

    Bispecific antibody therapy · Bone marrow transplant · Cancer treatment · CAR-T cell therapy · Chemotherapy · Complete blood count (CBC) · Creatinine test · CT ...

  5. Multiple myeloma - Doctors and departments - Mayo Clinic

    Bispecific antibody therapy · Bone marrow transplant · Cancer treatment · CAR-T cell therapy · Chemotherapy · Complete blood count (CBC) · Creatinine test · CT ...

  6. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic expert answers questions about antibody testing for COVID-19 ... Science Saturday: Antibody testing, in pictures featured image. Research.

  7. Medical Research & Education - Mayo Clinic News Network

    ... monoclonal[...] Latest stories. 7 advances in CAR-T cell therapy at Mayo Clinic featured image. Cancer. 7 advances in CAR-T cell therapy at Mayo Clinic. Mayo ...

  8. Combination Therapy Of Acalabrutinib, Venetoclax And Durvalumab To Treat Richter Transformation - Mayo Clinic

    Hepatitis B core antibody (anti-HBc) positive and who are surface antigen negative, and hepatitis B PCR positive will be excluded. These above patients once ...

  9. Compare The Efficacy And Safety Of Golcadomide Plus R-CHOP Vs Placebo Plus RCHOP In Participants With Previously Untreated High-risk Large B-cell Lymphoma - Mayo Clinic

    Participant has known chronic active hepatitis B (hepatitis B virus surface antigen [HBsAg] positive and/or hepatitis B core antibody [anti-HBc] positive ...

  10. A Study to Evaluate the Effectiveness and Safety of bb2121 in Subjects with Relapsed and Refractory Multiple Myeloma and in Subjects with Clinical High-Risk Multiple Myeloma - Mayo Clinic

    immunomodulatory agent and an anti-CD38 antibody - Subject has evidence of PD on or within 60 days of the most recent prior treatment regimen - Subject ...